Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies

Tyesha N. Burks, Ruth Marx-Rattner, Laura Powell, Jasma Rucker, Djahida Bedja, Elisa Heacock, Barbara J. Smith, Darren Brian Foster, David A Kass, Brian O'Rourke, Jeremy D Walston, Peter Abadir

Research output: Contribution to journalArticle

Abstract

Although the effects of aging and inflammation on the health of the cardiac muscle are well documented, the combined effects of aging and chronic inflammation on cardiac muscle are largely unknown. The renin-angiotensin system (RAS) has been linked independently to both aging and inflammation, but is understudied in the context of their collective effect. Thus, we investigated localized cardiac angiotensin II type I and type II receptors (AT1R, AT2R), downstream effectors, and phenotypic outcomes using mouse models of the combination of aging and inflammation and compared it to a model of aging and a model of inflammation. We show molecular distinction in the combined effect of aging and inflammation as compared to each independently. The combination maintained an increased AT1R:AT2R and expression of Nox2 and exhibited the lowest activity of antioxidants. Despite signaling pathway differences, the combined effect shared phenotypic similarities with aging including oxidative damage, fibrosis, and hypertrophy. These phenotypic similarities have dubbed inflammatory conditions as premature aging, but they are, in fact, molecularly distinct. Moreover, treatment with an AT1R blocker, losartan, selectively reversed the signaling changes and ameliorated adverse phenotypic effects in the combination of aging and inflammation as well as each independently.

Original languageEnglish (US)
Pages (from-to)11979-11993
Number of pages15
JournalOncotarget
Volume6
Issue number14
StatePublished - 2015

Fingerprint

Renin-Angiotensin System
Cardiomyopathies
Inflammation
Myocardium
Premature Aging
Angiotensin I
Losartan
Angiotensin II
Hypertrophy
Fibrosis
Antioxidants
Health

Keywords

  • Aging
  • AT1R
  • Heart
  • Inflammation
  • Mitochondria

ASJC Scopus subject areas

  • Oncology

Cite this

Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies. / Burks, Tyesha N.; Marx-Rattner, Ruth; Powell, Laura; Rucker, Jasma; Bedja, Djahida; Heacock, Elisa; Smith, Barbara J.; Foster, Darren Brian; Kass, David A; O'Rourke, Brian; Walston, Jeremy D; Abadir, Peter.

In: Oncotarget, Vol. 6, No. 14, 2015, p. 11979-11993.

Research output: Contribution to journalArticle

@article{4690b89baf474b5eb41b1ac981afd1c3,
title = "Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies",
abstract = "Although the effects of aging and inflammation on the health of the cardiac muscle are well documented, the combined effects of aging and chronic inflammation on cardiac muscle are largely unknown. The renin-angiotensin system (RAS) has been linked independently to both aging and inflammation, but is understudied in the context of their collective effect. Thus, we investigated localized cardiac angiotensin II type I and type II receptors (AT1R, AT2R), downstream effectors, and phenotypic outcomes using mouse models of the combination of aging and inflammation and compared it to a model of aging and a model of inflammation. We show molecular distinction in the combined effect of aging and inflammation as compared to each independently. The combination maintained an increased AT1R:AT2R and expression of Nox2 and exhibited the lowest activity of antioxidants. Despite signaling pathway differences, the combined effect shared phenotypic similarities with aging including oxidative damage, fibrosis, and hypertrophy. These phenotypic similarities have dubbed inflammatory conditions as premature aging, but they are, in fact, molecularly distinct. Moreover, treatment with an AT1R blocker, losartan, selectively reversed the signaling changes and ameliorated adverse phenotypic effects in the combination of aging and inflammation as well as each independently.",
keywords = "Aging, AT1R, Heart, Inflammation, Mitochondria",
author = "Burks, {Tyesha N.} and Ruth Marx-Rattner and Laura Powell and Jasma Rucker and Djahida Bedja and Elisa Heacock and Smith, {Barbara J.} and Foster, {Darren Brian} and Kass, {David A} and Brian O'Rourke and Walston, {Jeremy D} and Peter Abadir",
year = "2015",
language = "English (US)",
volume = "6",
pages = "11979--11993",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "14",

}

TY - JOUR

T1 - Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies

AU - Burks, Tyesha N.

AU - Marx-Rattner, Ruth

AU - Powell, Laura

AU - Rucker, Jasma

AU - Bedja, Djahida

AU - Heacock, Elisa

AU - Smith, Barbara J.

AU - Foster, Darren Brian

AU - Kass, David A

AU - O'Rourke, Brian

AU - Walston, Jeremy D

AU - Abadir, Peter

PY - 2015

Y1 - 2015

N2 - Although the effects of aging and inflammation on the health of the cardiac muscle are well documented, the combined effects of aging and chronic inflammation on cardiac muscle are largely unknown. The renin-angiotensin system (RAS) has been linked independently to both aging and inflammation, but is understudied in the context of their collective effect. Thus, we investigated localized cardiac angiotensin II type I and type II receptors (AT1R, AT2R), downstream effectors, and phenotypic outcomes using mouse models of the combination of aging and inflammation and compared it to a model of aging and a model of inflammation. We show molecular distinction in the combined effect of aging and inflammation as compared to each independently. The combination maintained an increased AT1R:AT2R and expression of Nox2 and exhibited the lowest activity of antioxidants. Despite signaling pathway differences, the combined effect shared phenotypic similarities with aging including oxidative damage, fibrosis, and hypertrophy. These phenotypic similarities have dubbed inflammatory conditions as premature aging, but they are, in fact, molecularly distinct. Moreover, treatment with an AT1R blocker, losartan, selectively reversed the signaling changes and ameliorated adverse phenotypic effects in the combination of aging and inflammation as well as each independently.

AB - Although the effects of aging and inflammation on the health of the cardiac muscle are well documented, the combined effects of aging and chronic inflammation on cardiac muscle are largely unknown. The renin-angiotensin system (RAS) has been linked independently to both aging and inflammation, but is understudied in the context of their collective effect. Thus, we investigated localized cardiac angiotensin II type I and type II receptors (AT1R, AT2R), downstream effectors, and phenotypic outcomes using mouse models of the combination of aging and inflammation and compared it to a model of aging and a model of inflammation. We show molecular distinction in the combined effect of aging and inflammation as compared to each independently. The combination maintained an increased AT1R:AT2R and expression of Nox2 and exhibited the lowest activity of antioxidants. Despite signaling pathway differences, the combined effect shared phenotypic similarities with aging including oxidative damage, fibrosis, and hypertrophy. These phenotypic similarities have dubbed inflammatory conditions as premature aging, but they are, in fact, molecularly distinct. Moreover, treatment with an AT1R blocker, losartan, selectively reversed the signaling changes and ameliorated adverse phenotypic effects in the combination of aging and inflammation as well as each independently.

KW - Aging

KW - AT1R

KW - Heart

KW - Inflammation

KW - Mitochondria

UR - http://www.scopus.com/inward/record.url?scp=84931364207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931364207&partnerID=8YFLogxK

M3 - Article

C2 - 26221650

AN - SCOPUS:84931364207

VL - 6

SP - 11979

EP - 11993

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 14

ER -